Citation Impact
Citing Papers
Major Depressive Disorder
2000
The Medical Management of Depression
2005
Continuation and maintenance therapy with antidepressive agents
1991
Hoxb8 Is Required for Normal Grooming Behavior in Mice
2002 StandoutNobel
Structural basis for triplet repeat disorders: a computational analysis
1999 StandoutNobel
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
1998 Standout
Schizophrenia
2009 Standout
Long-Acting Risperidone
2004
C. elegans Locomotory Rate Is Modulated by the Environment through a Dopaminergic Pathway and by Experience through a Serotonergic Pathway
2000 StandoutNobel
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
2008 Standout
A Phospho-Switch Controls the Dynamic Association of Synapsins with Synaptic Vesicles
1999 StandoutNobel
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
1990 StandoutNature
Measuring inconsistency in meta-analyses
2003 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
The Serotonin Syndrome
2005 Standout
Neurobiology of Depression
2002 Standout
Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia
1998 StandoutNobel
Major Depressive Disorder
2008 Standout
Whole Brain Segmentation
2002 Standout
Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications
1987
Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications
2003
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
Cerebral Structural Abnormalities in Obsessive-compulsive Disorder
1996
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Neurobiological issues in Tourette syndrome
1994
Reward and Abuse of Opiates
1992
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Differential Regulation of Dopamine D1A Receptor Responsiveness by Various G Protein-coupled Receptor Kinases
1996 StandoutNobel
Cerebrospinal fluid measures of neurotransmitter changes associated with pharmacological alteration of the despair response to social separation in rhesus monkeys
1984
The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats
1986 StandoutNobel
Neurogenetic Adaptive Mechanisms in Alcoholism
1987 StandoutScience
Immunocytochemistry with internally labeled monoclonal antibodies.
1982 StandoutNobel
Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
1983 StandoutNature
Aminergic neurons: State control and plasticity in three model systems
1981
Huntington??s Disease
1999
Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)
2006
The serotonin syndrome and its treatment
1999
The role of hormone receptors and GTP-regulatory proteins in membrane transduction
1980 StandoutNatureNobel
Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors.
1980 Standout
Opposite effects of naloxone on substance P-induced changes in brain dopa synthesis and in locomotor activity in rats
1979 StandoutNobel
The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia
1987 Standout
Protein phosphorylation in the brain
1983 Nature
Pharmacological specificity of brain histamine H2-receptors differs in intact cells and cell-free preparations
1980 Nature
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Identification of a Peptide Specific for Aplysia Sensory Neurons by PCR-based Differential Screening
1991 StandoutScienceNobel
Solubilization and Characterization of Histamine H1 receptors in brain.
1982
"Negative Symptoms": Conceptual and Methodological Problems
1985
[16] Techniques for measuring the interaction of drugs with calmodulin
1983
How antipsychotics work—From receptors to reality
2006
Neurotensin and its amide analogue [Gln4]-neurotensin: effects on brain monoamine turnover
1978 StandoutNobel
Multiple receptors for dopamine
1979 StandoutNature
Neuronal inhibition by the peptide FMRFamide involves opening of S K+ channels
1987 StandoutNatureNobel
8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity
1982 StandoutNobel
Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.
1984 StandoutNobel
Cyclic AMP-dependent protein kinase closes the serotonin-sensitive K+channels of Aplysia sensory neurones in cell-free membrane patches
1985 StandoutNatureNobel
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Genetic control of ethanol action on the central nervous system
1977
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Antagonism of Catecholamine Receptor Signaling by Expression of Cytoplasmic Domains of the Receptors
1993 StandoutScienceNobel
A family of genes that codes for ELH, a neuropeptide eliciting a stereotyped pattern of behavior in Aplysia
1982 StandoutNobel
Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP
1983 StandoutNobel
Antipsychotic Drugs, Neurotransmitters, and Schizophrenia
1978 StandoutNobel
Peptidergic neurones
1980 Nature
The Dopamine Hypothesis of Schizophrenia: A Review*
1976
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
1990 StandoutScience
Regioselective synthesis of 3-aryl substituted pyrrolidines via palladium catalyzed arylation: pharmacological evaluation for central dopaminergic and serotonergic activity.
1997 StandoutNobel
An endogenous protein modulates the affinity of GABA and benzodiazepine receptors in rat brain
1978 Nature
5-HT1A and histamine H1 receptors in HeLa cells stimulate phosphoinositide hydrolysis and phosphate uptake via distinct G protein pools.
1991 StandoutNobel
Synapsins: Mosaics of Shared and Individual Domains in a Family of Synaptic Vesicle Phosphoproteins
1989 StandoutScienceNobel
An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system
1985 StandoutNobel
Dopamine Receptors: From Structure to Function
1998 Standout
(+)-AJ 76 and (+)-UH 232: Central stimulants acting as preferential dopamine autoreceptor antagonists
1986 StandoutNobel
Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder
1998
Response of central monoaminergic neurons to lisuride: Comparison with LSD
1979
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
1983 StandoutScience
Selective antagonists of benzodiazepines
1981 StandoutNature
Works of J. Ananth being referenced
Drug Therapy in Schizophrenia
2004
Side Effects of Atypical Antipsychotic Drugs
2004
The Use of Methyldopa in Schizophrenia: A Review and Comparative Study
1972
FLUVOXAMINE
1984
Psychopharmacology: A Generation of Progress
1979
How do the atypical antipsychotics work?
2001
Drug-Induced Mood Disorders
1980
Nuclear magnetic resonance study of obsessive-compulsive disorder
1989
Genetics and Psychopharmacology
1976
Tricyclic continuation and maintenance therapy in unipolar depression
1981
A review of combined tricyclic and MAOI therapy
1977
Side effects in the neonate from psychotropic agents excreted through breast-feeding
1978
Lithium Carbonate in the Treatment of Movement Disorders
1980